Earnings Bonanza: Exclusive Stock Alert Inside!

Earnings Alert. If you cannot see this email properly, please click [here]( --------------------------------------------------------------- Sponsor Message [Americans Now Favor Gold Over Stocks as an Investment Vehicle]( [See why investors are so impressed by this overlooked gold investment strategy.]( --------------------------------------------------------------- February 12, 2024 (Earnings Report) From the desk of the Editor Dear Reader, We just identified several stocks that are expected to release earnings very soon. If you are interested in any of these companies, we encourage you to do your own research and due diligence before pursuing any investments. Keep in mind, the actual earnings date and time may change, so if you’re interested in any of these companies you will need to pay close attention to their announcements. --------------------------------------------------------------- Sponsor Message [Gold Could Be Heading for Record Highs - But How to Play It?]( to FX Empire, the gold forecast is now bullish, with support for a $3,000 target in 2024. The big question is how to play it. Some investors are discovering a unique gold investment alternative that sidesteps the major issues with gold mining stocks or physical gold. [See this little-known way to play in the rising gold market.]( --------------------------------------------------------------- [Roivant Sciences Ltd.]( Symbol: [ROIV]( Recent Price: $10.81 Average Analyst Price Target: $15.33 (41.84%) Market Cap: $8.69B Last Year's EPS: $-0.38 Consensus EPS Forecast: $-0.28 Expected Earnings Date: Feb 13, 2024 Recent Analyst Action: Allison Bratzel, analyst at Piper Sandler, reiterates coverage on [Roivant Sciences Ltd. (ROIV)]( in the Healthcare sector with a Buy rating and a price target of $20 (1 month ago). [TipRanks.com]( also reports that [Roivant Sciences Ltd.]( currently has 3 analysts offering 12-month price targets and the consensus is a Buy rating with an average price target is $15.33 . The target pricing ranges from a high forecast of $20 down to a low forecast of $12. [Roivant Sciences Ltd. (ROIV)](’s last closing price was $10.81 which would put the average price target at 41.84% upside. Here are 3rd party ratings for [ROIV](: - TipRanks.com: Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: buy - Zacks.com: Hold, Top 39% (97 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [URGENT: Don't risk your retirement]( looming recession, inflation, unpayable debt, a failing dollar, and a crumbling housing market all put your savings in extreme risk. Protect your retirement with this free guide that shows you how to guard your money against economic downturns with gold. Take action NOW, before it’s too late, Download your free guide and see for yourself why gold is the #1 safe haven for smart investors. [Protect your retirement with this free gold guide]( --------------------------------------------------------------- [Nurix Therapeutics, Inc.]( Symbol: [NRIX]( Recent Price: $8.85 Average Analyst Price Target: $30.60 (245.76%) Market Cap: $429.26M Last Year's EPS: $-0.45 Consensus EPS Forecast: $-0.69 Expected Earnings Date: Feb 13, 2024 Recent Analyst Action: Joseph Catanzaro, analyst at Piper Sandler, reiterates coverage on [Nurix Therapeutics, Inc. (NRIX)]( in the Healthcare sector with a Buy rating and a price target of $35 (1 week ago). [TipRanks.com]( also reports that [Nurix Therapeutics, Inc.]( currently has 5 analysts offering 12-month price targets and the consensus is a Buy rating with an average price target is $30.60 . The target pricing ranges from a high forecast of $35 down to a low forecast of $24. [Nurix Therapeutics, Inc. (NRIX)](’s last closing price was $8.85 which would put the average price target at 245.76% upside. Here are 3rd party ratings for [NRIX](: - TipRanks.com: Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: buy - Zacks.com: Sell, Top 39% (97 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- [Cybin Inc.]( Symbol: [CYBN]( Recent Price: $0.32 Average Analyst Price Target: $4.70 (1,368.75%) Market Cap: $130.83M Last Year's EPS: $-0.05 Consensus EPS Forecast: $-0.05 Expected Earnings Date: Feb 13, 2024 Recent Analyst Action: Francois Brisebois, analyst at Oppenheimer, reiterates coverage on [Cybin Inc. (CYBN)]( in the Healthcare sector with a Buy rating and a price target of $4.5 (1 month ago). [TipRanks.com]( also reports that [Cybin Inc.]( currently has 5 analysts offering 12-month price targets and the consensus is a Buy rating with an average price target is $4.70 . The target pricing ranges from a high forecast of $6 down to a low forecast of $3. [Cybin Inc. (CYBN)](’s last closing price was $0.32 which would put the average price target at 1,368.75% upside. Here are 3rd party ratings for [CYBN](: - TipRanks.com: Buy - TradingView.com: Sell - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Sell, Top 39% (97 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Harry Truman + Joe Biden = US Voters Spied On in 2024]( Harry Truman started in 1947… Joe Biden is finishing in the 2024 election. A "4th branch" of the US government that operates in secrecy and without accountability…. Will roll out Rule 613 – a mass spy program. [See disturbing evidence of their mass citizen surveillance program here.]( --------------------------------------------------------------- [Presto Automation, Inc.]( Symbol: [PRST]( Recent Price: $0.20 Average Analyst Price Target: $1.37 (586.67%) Market Cap: $13.35M Last Year's EPS: $-0.78624 Consensus EPS Forecast: $-0.24 Expected Earnings Date: Feb 13, 2024 Recent Analyst Action: Samad Samana, analyst at Jefferies, reiterates coverage on [Presto Automation, Inc. (PRST)]( in the Technology sector with a Hold rating and a price target of $0.62 (1 month ago). [TipRanks.com]( also reports that [Presto Automation, Inc.]( currently has 3 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $1.37 . The target pricing ranges from a high forecast of $2 down to a low forecast of $0.62. [Presto Automation, Inc. (PRST)](’s last closing price was $0.20 which would put the average price target at 586.67% upside. Here are 3rd party ratings for [PRST](: - TipRanks.com: Hold - TradingView.com: Sell - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Top 39% (97 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- [Electromed, Inc.]( Symbol: [ELMD]( Recent Price: $10.38 Average Analyst Price Target: $20.50 (97.50%) Market Cap: $89.08M Last Year's EPS: $0.12 Consensus EPS Forecast: $0.1 Expected Earnings Date: Feb 13, 2024 Recent Analyst Action: Brooks O'Neil, analyst at Lake Street, reiterates coverage on [Electromed, Inc. (ELMD)]( in the Healthcare sector with a Buy rating and a price target of $26 (2 months ago). [TipRanks.com]( also reports that [Electromed, Inc.]( currently has 2 analysts offering 12-month price targets and the consensus is a Buy rating with an average price target is $20.50 . The target pricing ranges from a high forecast of $26 down to a low forecast of $15. [Electromed, Inc. (ELMD)](’s last closing price was $10.38 which would put the average price target at 97.50% upside. Here are 3rd party ratings for [ELMD](: - TipRanks.com: Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: sell - Zacks.com: n/a, n/a [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [My Gift to You]( I have arranged for you to receive [a complimentary 3-month subscription]( to Bernie Schaeffer’s Option Advisor online newsletter. [CLICK HERE]( for 3 Months FREE of Bernie Schaeffer’s Option Advisor ($395 Retail Value - [FREE!]() --------------------------------------------------------------- [AutoNation, Inc.]( Symbol: [AN]( Recent Price: $152.17 Average Analyst Price Target: $178.20 (17.11%) Market Cap: $6.47B Last Year's EPS: $6.29 Consensus EPS Forecast: $5.49 Expected Earnings Date: Feb 13, 2024 Recent Analyst Action: Douglas Dutton, analyst at Evercore ISI, reiterates coverage on [AutoNation, Inc. (AN)]( in the Consumer Cyclical sector with a Buy rating and a price target of $185 (3 weeks ago). [TipRanks.com]( also reports that [AutoNation, Inc.]( currently has 5 analysts offering 12-month price targets and the consensus is a Buy rating with an average price target is $178.20 . The target pricing ranges from a high forecast of $255 down to a low forecast of $142. [AutoNation, Inc. (AN)](’s last closing price was $152.17 which would put the average price target at 17.11% upside. Here are 3rd party ratings for [AN](: - TipRanks.com: Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: Hold, Bottom 10% (224 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- [Primerica, Inc.]( Symbol: [PRI]( Recent Price: $242.46 Average Analyst Price Target: $216.25 (-10.81%) Market Cap: $8.49B Last Year's EPS: $3.99 Consensus EPS Forecast: $4.03 Expected Earnings Date: Feb 13, 2024 Recent Analyst Action: Wilma Burdis, analyst at Raymond James, reiterates coverage on [Primerica, Inc. (PRI)]( in the Financial Services sector with a Hold rating (9 hours ago). [TipRanks.com]( also reports that [Primerica, Inc.]( currently has 4 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $216.25 . The target pricing ranges from a high forecast of $260 down to a low forecast of $200. [Primerica, Inc. (PRI)](’s last closing price was $242.46 which would put the average price target at -10.81% upside. Here are 3rd party ratings for [PRI](: - TipRanks.com: Hold - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Buy, Top 19% (48 out of 250) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [The Strategic Gold Play You Haven't Heard About]( recommend adding gold to your portfolio, but in what form? Some savvy investors are now rejecting coins and mining stocks in favor of a unique gold investment alternative. It holds explosive growth potential similar to a junior gold stock -- but with less risk exposure. [Get the full story on this overlooked gold investment strategy here.]( --------------------------------------------------------------- And there you have it--- Stocks expected to release earnings soon... Sincerely, The Editor, MarketTickerPress.com Market Ticker Press Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. By opening and/or clicking a link containted within this email, you are reconfirming your opt-in status. You can unsubscribe at any time. [If you are not a human, click here.]( MarketTickerPress.com part of Sandpiper Marketing Group | 1519 Mecklenburg Hwy | Unit 4 | Mt. Mourne | North Carolina | 28123 | United States | 877-411-9808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software